Home
Mail
Search
News
Sports
Finance
Celebrity
Weather
Answers
Flickr
Mobile
More
Politics
Movies
Music
TV
Groups
Style
Beauty
Tech
Shopping
Autos
Try Yahoo Finance on Firefox
»
Yahoo Finance
Search Finance
Search Web
Sign In
Mail
Help
Account Info
Help
Suggestions
Yahoo
Home
Finance Home
My Portfolio
View All Portfolios
Create Portfolio
My Quotes News
Market Data
Stocks
Mutual Funds
Options
ETFs
Bonds
Commodities
Currencies
Calendars
Yahoo Originals
Market Movers
Midday Movers
The Final Round
Business
Investing
Personal Finance
Breakout
Cost of Living
The Daily Ticker
Driven
Hot Stock Minute
Just Explain It
Aaron Task
Michael Santoli
Jeff Macke
Aaron Pressman
Rick Newman
Mandi Woodruff
The Exchange
Unexpected Returns
Philip Pearlman
Andy Serwer, Editor
Daniel Roberts
Nicole Sinclair
Melody Hahm
Business & Finance
Company News
Economic News
Market News
Personal Finance
Career & Education
Real Estate
Retirement
Credit & Debt
Taxes
Autos
Health & Lifestyle
Featured Videos
Rates in Your Area
Calculators
Tools
CNBC
Big Data Download
Off the Cuff
Power Pitch
Talking Numbers
The Biz Fix
Top/Best/Most
Contributors
Search for share prices
Enter Symbol
Finance Search
Tue, Mar 29 2016, 10:01am EDT - U.S. Markets close in 5 hrs 59 mins
Dow
0.23%
Nasdaq
0.04%
More on KBIO
KaloBios Pharmaceuticals, Inc. (KBIOQ)
Watchlist
10.45
-3.05
(
22.59%
)
OTC Markets -
As of
9:46AM EDT
|
Sponsored
Recent Articles
Shkreli's Bankrupt Drug Company Gets Offer From Hedge Fund
at Bloomberg
Fri Mar 11 2016
KALOBIOS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online
Fri Mar 04 2016
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against KaloBios Pharmaceuticals, Inc. (KBIO) and Lead Plaintiff Deadline: February 16, 2016
Accesswire
Mon Feb 15 2016
2-DAY DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against KaloBios Pharmaceuticals, Inc. and Reminds Investors with Losses in Excess of $200,000 to Contact the Firm
Business Wire
Mon Feb 15 2016
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investments in KaloBios Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – KBIOQ
GlobeNewswire
Sun Feb 14 2016
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $50,000 Investing In KaloBios Pharmaceuticals, Inc. To Contact The Firm Before Imminent Lead Plaintiff Deadline
PR Newswire
Sat Feb 13 2016
Sponsored
Pharma bro Martin Shkreli hit with $4.6M tax lien
at CNBC
Fri Feb 12 2016
SHAREHOLDER ALERT: Lundin Law PC Announces Ongoing Investigation of KaloBios Pharmaceuticals, Inc. and Urges Investors with Losses in Excess of $250,000 to Contact the Firm
Business Wire
Wed Feb 10 2016
February 16 Deadline Alert: The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of KaloBios Pharmaceuticals, Inc. Investors
Business Wire
Wed Feb 10 2016
Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against KaloBios Pharmaceuticals, Inc. (KBIO) and Lead Plaintiff Deadline: February 16, 2016
Accesswire
Wed Feb 10 2016
Prev Close
13.50
High
13.99
Open
13.99
Low
10.25
Volume
20.8k
52 Wk High
45.82
Mkt Cap
43.09M
52 Wk Low
0.44
Avg Vol
38.6k
P/E
1Y Target Est
5.00
EPS
-8.11
Beta
0.64
Div & Yield
N/A